Literature DB >> 29797309

Eosinophilic fasciitis and lichen sclerosus in a patient treated with nivolumab.

Juan-José Andrés-Lencina1, Sara Burillo-Martínez1, Raquel Aragón-Miguel1, Alba Calleja-Algarra1, José-Luis Rodríguez-Peralto2, Pablo-Luis Ortiz-Romero1, Vanessa Gargallo-Moneva1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29797309     DOI： 10.1111/ajd.12836

Source DB:  PubMed          Journal:  Australas J Dermatol        ISSN： 0004-8380            Impact factor:   2.875


× No keyword cloud information.
  5 in total

1.  Nivolumab-induced multiple morphea associated with eosinophilic fasciitis.

Authors:  Marouschka Lacombe; Christophe Bedane; Stéphanie Delaumenie; Philippe Bernard
Journal:  Eur J Dermatol       Date:  2021-12-01       Impact factor: 3.328

Review 2.  Eosinophilic Fasciitis Following Checkpoint Inhibitor Therapy: Four Cases and a Review of Literature.

Authors:  Karmela Kim Chan; Cynthia Magro; Alexander Shoushtari; Charles Rudin; Veronica Rotemberg; Anthony Rossi; Cecilia Lezcano; John Carrino; David Fernandez; Michael A Postow; Arlyn Apollo; Mario E Lacouture; Anne R Bass
Journal:  Oncologist       Date:  2019-10-15

3.  Moderate-to-severe eosinophilia induced by treatment with immune checkpoint inhibitors: 37 cases from a national reference center for hypereosinophilic syndromes and the French pharmacovigilance database.

Authors:  Quentin Scanvion; Johana Béné; Sophie Gautier; Aurélie Grandvuillemin; Christine Le Beller; Chouki Chenaf; Nicolas Etienne; Solenn Brousseau; Alexis B Cortot; Laurent Mortier; Delphine Staumont-Sallé; Franck Morschhauser; Alexandra Forestier; Matthieu Groh; David Launay; Eric Hachulla; Myriam Labalette; Jean-Emmanuel Kahn; Guillaume Lefèvre
Journal:  Oncoimmunology       Date:  2020-04-07       Impact factor: 8.110

4.  Eosinophilic fasciitis induced by nivolumab therapy managed without treatment interruption or systemic immunosuppression.

Authors:  Ai-Tram N Bui; Caroline A Nelson; Christine G Lian; Alvaro Laga Canales; Nicole R LeBoeuf
Journal:  JAAD Case Rep       Date:  2020-04-25

5.  Immune Checkpoint Inhibitor-Associated Scleroderma-Like Syndrome: A Report of a Pembrolizumab-Induced "Eosinophilic Fasciitis-Like" Case and a Review of the Literature.

Authors:  Christina Salamaliki; Elena E Solomou; Stamatis-Nick C Liossis
Journal:  Rheumatol Ther       Date:  2020-10-16
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.